 |
 Ulrike Fiedler, Ph.D., CEO
Ulrike Fiedler took over the CEO position in 2000. Before she was Head of a Medical Research Laboratory at the University of Dresden and Head of the Scaffold Display Group at the University of Halle. Earlier she worked as a scientist and Post-Doc at the Leibniz Institute (IPK) in Gatersleben.
|
 Frank Ubags, COO
After 18 years in petrochemical and packaging, Frank Ubags was CFO at Rhein Biotech (Düsseldorf, Maastricht). He executed the IPO in 1999 as well as several M&A transactions in Asia and South America. After the takeover by Berna Biotech he was responsible for the sale of Rhein Biotech Düsseldorf to Dynavax (USA) in 2006. Later on he was CFO at Kiadis Pharma
(Amsterdam, Montreal). He joined Scil Proteins in 2009.
|
 Henning Afflerbach, Ph.D., CBO
Henning Afflerbach joined Scil Proteins as CBO in 2009. Before that time he has been
holding different management positions within the biotechnology industry for
more than 10 years. He was in charge of the business
development of the companies Peptor GmbH/Ltd (Rehovot/Erkrath), Develogen
(Göttingen), and DIREVO Biotech (Cologne).
 Ulrich Haupts, Ph.D., CSO
Ulrich Haupts has a broad
expertise in the areas of protein optimization and assay development. During
his career he held research and managerial positions at SmithKline Beecham,
Direvo Biotech and Bayer Healthcare. He joined Scil in 2011 coming from
Bayer Healthcare where he was Director of Protein Optimization. |
|
|
|
|
